Physician-related barriers to hypertension management

Medical Principles and Practice

Volumn 13, Issue 5, 2004, Pages 282-285

  Wang, Lexin ^a  

^a CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Hypertension management barriers; WHO ISH guidelines

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; POTASSIUM;

BLOOD PRESSURE MEASUREMENT; DIET; EXERCISE; HEALTH SURVEY; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOTENSION; LIFESTYLE; MEDICAL SPECIALIST; MONOTHERAPY; PATIENT CARE; PHYSICIAN; PRACTICE GUIDELINE; QUESTIONNAIRE; REVIEW; STROKE; WEIGHT REDUCTION;

ANTIHYPERTENSIVE AGENTS; ATTITUDE OF HEALTH PERSONNEL; CHINA; CLINICAL COMPETENCE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HUMANS; HYPERTENSION; LIFE STYLE; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PRACTICE GUIDELINES;

EID: 4444315339     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079528     Document Type: Review

References (17)

1. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997;157:2413-2446.
2. Berlowitz, DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Quadra B, Moskowitz MA: Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998;339:1957-1963.
3. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A: Blood-pressure control in the hypertensive population. Lancet 1997;349:454-457.
4. Fagard RH, Van den Enden M, Leeman M, Warling X: Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens 2002;20:1297-1302.
5. Colhoun HM, Dong W, Poulter NR: Blood pressure screening, management and control in England - results from the health survey for England 1994. J Hypertens 1998;16:747-752.
6. Tao SQ, Wu XG, Duan XF, Fang WQ, Hao JS, Fan DJ, Wang WZ, Li Y: Hypertension prevalence and status of awareness, treatment and control in China. Chin Med J 1995;108:483-489.
7. Anonymous: Management of patient compliance in the treatment of hypertension: Report of the NHLBI Working Group. Hypertension 1982;4:415-423.
8. Hedner T, Falk M: Physician and patient evaluation of hypertension-related risks and benefits from treatment. Blood Press 1997;6:26-34.
9. Hosie J, Wiklund I: Managing hypertension in general practice: Can we do better? J Hum Hypertens 1995;9:515-518.
10. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GL, Berlowitz DR, Asch SM: Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002;162:413-423.
11. Guidelines Subcommittee. 1999 World Health Orgnization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999;17:151-183.
12. Chobanian AV: Control of hypertension - an important national priority. N Engl J Med 2001;345:534-535.
13. Douglas JG, Ferdinand KC, Bakris GL, Sowers JR: Barriers to blood pressure control in African Americans. Overcoming obstacles is challenging, but goals can be attained. Postgrad Med 2002;112:51-56.
14. National Institutes of Health: Diagnosis and Management of Hypertension -1987: A Nationwide Survey of Physicians' Knowledge, Attitudes, and Reported Behavior. Bethesda: National Heart, Lung, and Blood Institute, US Dept of Health and Human Services, 1989. NIH publication 89-2968.
15. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR: The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990;150:1881-1884.
16. Haynes RB, McKibbon KA, Kanani R: Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996;348:383-386.
17. Anonymous: Major cardiovascular events in hypertensive patients randomised to doxazosin vs. chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA 2000;283:1967-1975.